IGF2 and neoplasm: IGF-IIR, known as the cation-independent mannose-6-phosphate receptor, acts as a reservoir to clear IGF-II from the extracellular environment and cell surface through endocytosis and lysosomal degradation, thereby inhibiting IGF-II-induced tumor growth signaling [66–68].